Since numerous therapeutic combination therapies, including targeting the CD39/adenosine pathway, are being explored in cancer patients, it is hoped that targeting the CD39/adenosine pathway will improve the treatment effects of ART in PLWH. Here, ENTPD1 is linked to cancer.